These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2763269)

  • 1. Protein C assays in uremia.
    Sørensen PJ; Knudsen F; Nielsen AH; Dyerberg J
    Thromb Res; 1989 May; 54(4):301-10. PubMed ID: 2763269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations of protein C in uremic hemodialysed patients.
    Nguyen P; Toupance O; Chanard J; Potron G
    Thromb Res; 1993 Mar; 69(6):509-18. PubMed ID: 8503120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C activity in renal disease.
    Sørensen PJ; Knudsen F; Nielsen AH; Dyerberg J
    Thromb Res; 1985 May; 38(3):243-9. PubMed ID: 3839607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C and protein S levels in uremic patients before and after dialysis.
    Demicheli M; Contino L; Iberti M; Ortensia A; Finotto E; Lombardi A; Preda L
    Thromb Res; 1992 Dec; 68(6):451-7. PubMed ID: 1341055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations of the defective protein C in hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis.
    Sørensen PJ; Nielsen AH; Knudsen F; Dyerberg J
    Blood Purif; 1989; 7(4):218-22. PubMed ID: 2775514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
    Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
    Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective protein C in uraemia.
    Sørensen PJ; Nielsen AH; Knudsen F; Dyerberg J
    Blood Purif; 1987; 5(1):29-32. PubMed ID: 3790269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma.
    Faioni EM; Franchi F; Krachmalnicoff A; Valsecchi C; Viganò GL; Remuzzi G; Mannucci PM
    Thromb Haemost; 1991 Oct; 66(4):420-5. PubMed ID: 1796390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.
    Girndt M; Sester M; Sester U; Kaul H; Köhler H
    Kidney Int; 2001 Apr; 59(4):1382-9. PubMed ID: 11260399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays.
    España F; Estellés A; Aznar J; Gilabert J
    Thromb Res; 1986 Dec; 44(6):771-82. PubMed ID: 3798419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP, IL‑2 and TNF‑α level in patients with uremia receiving hemodialysis.
    Li G; Ma H; Yin Y; Wang J
    Mol Med Rep; 2018 Feb; 17(2):3350-3355. PubMed ID: 29257244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
    Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
    Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The peripheral blood levels of TNF alpha and PLA2 activities in dialysis and non-dialysis patients with uremia].
    Duan S; Luo J; Liu F
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):78-80. PubMed ID: 9868037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C and renal pathology in Ivory Coast population.
    Blavy G; Koffi D
    Nouv Rev Fr Hematol (1978); 1991; 33(5):359-61. PubMed ID: 1666429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.